4519:TYO
Chugai Pharmaceutical Co Ltd
¥7,181.00
arrow_upward
+0.46%(+33.00) 1D
Nov 13, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4519...
Open
¥7,084
High
¥7,230
Low
¥7,084
Mkt. cap
12.06T
Avg. vol.
3.58M
Volume
2.05M
Dividend
1.92%
Quarterly dividend
¥34
Ex-dividend date
Jun 29, 2026
P/E ratio
23.46
52-wk high
¥10,700
52-wk low
¥5,974
EPS
¥306
Shares outstanding
547.19M
No. of employees
5K
Open
¥7,084
High
¥7,230
Low
¥7,084
Mkt. cap
12.06T
Avg. vol.
3.58M
Volume
2.05M
Dividend
1.92%
Quarterly dividend
¥34
Ex-dividend date
Jun 29, 2026
P/E ratio
23.46
52-wk high
¥10,700
52-wk low
¥5,974
EPS
¥306
Shares outstanding
547.19M
No. of employees
5K
News stories
From web sources and news partners
Yahoo Finance
·
21 hours ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
CNBC
·
1 day ago
Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump
MarketWatch
·
12 hours ago
Stock Market on Nov. 13, 2026: Dow ends slightly higher, S&P 500 and Nasdaq fall as tech stocks struggle after Nvidia turmoil; U.S. equities market books weekly gain — live updates
ChartMill
·
21 minutes ago
Xencor (NASDAQ:XNCR): Strong Trend, Weak Setup
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitechugai-pharm.co.jp